Druggio Logo

Druggio

GlaxoSmithKline

GlaxoSmithKline is a pharmaceutical company founded in 2000 through a merger of Glaxo Wellcome and SmithKline Beecham. The company focuses on the development of prescription medicines, vaccines, and consumer healthcare products. Their drug portfolio includes treatments for a wide range of diseases, including respiratory, HIV, oncology, and infectious diseases. They also have a strong presence in the development of vaccines and healthcare products. Overall, GlaxoSmithKline is known for its extensive research and development efforts in the healthcare sector.

GlaxoSmithKline's Drugs

Allermist

Approval date

2009/4/22

Amerge

Approval date

2008/1/25

Anoro

Approval date

2014/7/4

Arepanrix

Approval date

2010/1/20

Arixtra

Approval date

2007/4/18

Arranon G

Approval date

2007/10/19

Arzerra

Approval date

2013/3/25

Avolve

Approval date

2009/7/7

Benlysta

Approval date

2017/9/27

Cervarix

Approval date

2009/10/16

Duvroq

Approval date

2020/6/29

Treats

Renal anemia
Encruse

Approval date

2015/3/26

Hepsera, Zefix

Approval date

2004/10/22

Hycamtin

Approval date

2000/12/22

Imigran

Approval date

2000/1/18

Lamictal

Approval date

2008/10/16

Lexiva

Approval date

2004/12/24

Malarone

Approval date

2012/12/25

Treats

Malaria
Nucala

Approval date

2016/3/28

ReQuip

Approval date

2006/10/20

Relvar

Approval date

2013/9/20

Revolade

Approval date

2010/10/27

Rotarix

Approval date

2011/7/1

Samtirel

Approval date

2012/1/18

Serevent

Approval date

2002/4/11

Tenozet

Approval date

2014/3/24

Tykerb

Approval date

2009/4/22

Volibris

Approval date

2010/7/23

Votrient

Approval date

2012/9/28

Xevudy

Approval date

2021/9/27

Treats

COVID-19
Xyzal

Approval date

2010/10/27

Zefix

Approval date

2000/9/22